J

Jaguar Health

D
JAGX
USD
-0.04
(-3.8462%)
Market Closed
5,319.00
Volume
-0.0419
EPS
-
Div Yield
0.20877
P/E
9,241,231.00
Market Cap
Today
-3.3816%
1 Week
-4.306%
1 Month
-22.481%
6 Months
-94.405%
12 Months
-93.675%
Year To Date
-88.948%
All Time
-99.995%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ACER
(%)
USD
A
ADMP
(%)
USD
A
AGEN
-0.275
(-6.5243%)
USD
A
AKRO
-0.405
(-1.1476%)
USD
A
APLT
0.09
(0.9326%)
USD
A
ASRT
0.01
(0.9901%)
USD
A
AVXL
-0.2
(-2.551%)
USD
A
AXGN
-2.28
(-14.6624%)
USD
B
BGNE
3.67
(1.8053%)
USD
B
BNGO
-0.0061
(-2.0327%)
USD

Title:
Jaguar Health Inc.

Sector:
Healthcare
Industry:
Biotechnology
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Do you need help or have a question?
Contact Us